High Gross MarginHigh gross profit relative to revenue indicates the company’s core offerings retain strong unit economics. Over a multi-month horizon, such margins give room to absorb fixed costs, speed recovery of operating profits if sales stabilize, and improve cash conversion as volumes recover.

Rising Asset BaseAn increase in total assets since 2023 provides tangible resources that can support operational rebuilding or serve as collateral for financing. This enlarged base offers strategic optionality over months for restructuring, working capital, or asset-based funding to stabilize operations.

Historically Clean Capital StructurePast periods with positive equity and no debt show the company previously operated with conservative financing and rebuild potential. That history implies management has operated without heavy leverage, suggesting feasible pathways to reestablish a healthier balance sheet if execution and funding align.

Bears Say

Collapsed RevenueA ~99% year-over-year revenue collapse is a severe structural impairment: it destroys scale, undermines customer and market relevance, and prevents effective absorption of fixed costs. Over months this materially raises the likelihood of prolonged losses and constrains recovery pathways.

Persistent Negative Cash FlowConsistent negative operating and free cash flow indicate ongoing cash burn that depletes reserves and forces reliance on external funding. Over a 2–6 month horizon this heightens refinancing, liquidity and covenant risks, limiting the firm’s ability to invest, market, or stabilize operations.

Deteriorated Balance Sheet / Zero EquityA meaningful rise in debt alongside reported equity of zero removes the shareholders' cushion and increases leverage and insolvency risk. Without equity buffer, the company faces constrained financing options, weaker creditor negotiating power, and greater vulnerability to operational shocks over months.

Teles AG Informationstechnologien News

Arzneiwerk AG VIDA to Save Costs by Ending Consolidated Financial Statements

Teles AG Informationstechnologien ( ($DE:TLIK) ) just unveiled an update. Arzneiwerk AG VIDA announced that it is no...

10M ago

Arzneiwerk AG VIDA Pre-Announces 2024 Financial Report

An update from Teles AG Informationstechnologien ( ($DE:TLIK) ) is now available. Arzneiwerk AG VIDA, a company based...

10M ago

TLIK FAQ

What was Teles AG Informationstechnologien’s price range in the past 12 months?

Teles AG Informationstechnologien lowest stock price was €0.14 and its highest was €0.72 in the past 12 months.

What is Teles AG Informationstechnologien’s market cap?

Teles AG Informationstechnologien’s market cap is €2.37M.

When is Teles AG Informationstechnologien’s upcoming earnings report date?

Teles AG Informationstechnologien’s upcoming earnings report date is Jun 01, 2026 which is in 105 days.

How were Teles AG Informationstechnologien’s earnings last quarter?

Currently, no data Available

Is Teles AG Informationstechnologien overvalued?

According to Wall Street analysts Teles AG Informationstechnologien’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Teles AG Informationstechnologien pay dividends?

Teles AG Informationstechnologien does not currently pay dividends.

What is Teles AG Informationstechnologien’s EPS estimate?

Teles AG Informationstechnologien’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Teles AG Informationstechnologien have?

Teles AG Informationstechnologien has 6,233,418 shares outstanding.

What happened to Teles AG Informationstechnologien’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Teles AG Informationstechnologien?

Currently, no hedge funds are holding shares in DE:TLIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Teles AG Informationstechnologien Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

-86.72%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Teles AG Informationstechnologien

Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.